首页> 美国卫生研究院文献>BMC Complementary and Alternative Medicine >Preliminary evaluation of anti-tuberculosis potential of siderophores against drug-resistant Mycobacterium tuberculosis by mycobacteria growth indicator tube-drug sensitivity test
【2h】

Preliminary evaluation of anti-tuberculosis potential of siderophores against drug-resistant Mycobacterium tuberculosis by mycobacteria growth indicator tube-drug sensitivity test

机译:用分枝杆菌生长指示剂-药物敏感性试验初步评估铁载体抗药性结核分枝杆菌的抗结核潜力

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundAlternative treatment strategies have become essential in overcoming the problem of drug-resistant Mycobacterium tuberculosis (Mtb). In this preliminary in vitro study, the anti-tuberculosis (anti-TB) activity of exogenous iron chelators (xenosiderophores) such as Exochelin-MS (Exo-MS) and Deferoxamine-B (DFO-B) was evaluated against ten multi-drug-resistant (MDR) and seven pyrazinamide-resistant (PZA R) Mtb isolates.
机译:背景技术在克服耐药性结核分枝杆菌(Mtb)问题方面,替代治疗策略已变得至关重要。在这项初步的体外研究中,评估了Exochelin-MS(Exo-MS)和Deferoxamine-B(DFO-B)等外源性铁螯合剂(异种铁载体)的抗结核(anti-TB)活性对十种多药的评价耐药株(MDR)和7种吡嗪酰胺耐药(PZA R )Mtb分离株。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号